LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD PH20 SC IN GENERALIZED MYASTHENIA GRAVIS: INTERIM ANALYSIS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY SERONEGATIVE PARTICIPANTS IN ADAPT-SC

被引：0
|
作者：
Bhavaraju-Sanka, Ratna
Howard, James F., Jr.
Vu, Tuan
De Bleecker, Jan L.
Utsugisawa, Kimiaki
Pasnoor, Mamatha
Sacca, Francesco
Korobko, Denis
Steeland, Sophie
Noukens, Jan
Van Hoorick, Benjamin
Liu, Li
Podhorna, Jana
Meisel, Andreas
Mantegazza, Renato
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
144
引用
收藏
页码：516 / 517
页数：2
相关论文
共 27 条
  • [21] Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study
    Chou, Cheng-Che
    Su, I-Chen
    Chou, I-Jun
    Lin, Jainn-Jim
    Lan, Shih-Yun
    Wang, Yi-Shan
    Kong, Shu-Sing
    Chen, Yun-Ju
    Hsieh, Meng-Ying
    Hung, Po-Cheng
    Wang, Huei-Shyong
    Chou, Min-Liang
    Lin, Kuang-Lin
    BMC NEUROLOGY, 2019, 19 (1) : 170
  • [22] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Meisel, Andreas
    Annane, Djillali
    Vu, Tuan
    Mantegazza, Renato
    Katsuno, Masahisa
    Aguzzi, Rasha
    Frick, Glen
    Gault, Laura F.
    Howard Jr, James
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3862 - 3875
  • [23] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Andreas Meisel
    Djillali Annane
    Tuan Vu
    Renato Mantegazza
    Masahisa Katsuno
    Rasha Aguzzi
    Glen Frick
    Laura Gault
    James F. Howard
    Journal of Neurology, 2023, 270 : 3862 - 3875
  • [24] LONG-TERM SAFETY AND EFFICACY OF ZILUCOPLAN IN GENERALIZED MYASTHENIA GRAVIS: 120-WEEK INTERIM ANALYSIS OF RAISE-XT
    Howard, James F., Jr.
    Freimer, Miriam
    Genge, Angela
    Hewamadduma, Channa
    Hussain, Yessar
    Maniaol, Angelina
    Mantegazza, Renato
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael D.
    Boroojerdi, Babak
    Duda, Petra W.
    Grimson, Fiona
    Vanderkelen, Mark
    Leite, M. Isabel
    MUSCLE & NERVE, 2024, 70 (03) : 548 - 548
  • [25] LONG-TERM EFFICACY AND SAFETY OF RAVULIZUMAB, A LONG-ACTING TERMINAL COMPLEMENT INHIBITOR, IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: RESULTS FROM THE PHASE 3 CHAMPION MG OPEN-LABEL EXTENSION
    Vu, Tuan
    Meisel, Andreas
    Mantegazza, Renato
    Annane, Djillali
    Katsuno, Masahisa
    Aguzzi, Rasha
    Rampal, Nishi
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 65 : S2 - S3
  • [26] LONG-TERM SAFETY AND EFFICACY OF NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS: VIVACITY-MG3 OPEN-LABEL INTERIM ANALYSIS
    Antozzi, Carlo
    Vu, Tuan
    Ramchandren, Sindhu
    Nowak, Richard J.
    Farmakidis, Constantine
    Bril, Vera
    De Bleecker, Jan
    Yang, Huan
    Minks, Eduard
    Park, Jin-Sung
    Grudniak, Mariusz
    Smilowski, Marek
    Sevilla, Teresa
    Hoffmann, Sarah
    Sivakumar, Kumaraswamy
    MUSCLE & NERVE, 2024, 70 (03) : 674 - 675
  • [27] Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
    Howard Jr, James F.
    Bresch, Saskia
    Farmakidis, Constantine
    Freimer, Miriam
    Genge, Angela
    Hewamadduma, Channa
    Hinton, John
    Hussain, Yessar
    Juntas-Morales, Raul
    Kaminski, Henry J.
    Maniaol, Angelina
    Mantegazza, Renato
    Masuda, Masayuki
    Nowak, Richard J.
    Sivakumar, Kumaraswamy
    Smilowski, Marek
    Utsugisawa, Kimiaki
    Vu, Tuan
    Weiss, Michael D.
    Zajda, Malgorzata
    Bloemers, Jos
    Boroojerdi, Babak
    Brock, Melissa
    de la Borderie, Guillemette
    Duda, Petra W.
    Vanderkelen, Mark
    Leite, M. Isabel
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
123